First Joint Call: Innovative approaches to address antibacterial resistance
Projects awarded funding within the 1st JPIAMR Joint Call
InnovaResistance, published in January 2014, was the first joint transnational call of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) consisting of 19 nations. The call was promoted by 14 funding agencies from 12 countries with a total budget of 13,8M€. “I am very pleased that we now have the first nominated projects within the Joint Programming Initiative on Antimicrobial Resistance,“ said Mats Ulfendahl, chair of the Management Board. The evaluation has been a two-stage process and a peer review panel based on scientific quality evaluated the proposed projects. Based on the recommendation and available funding seven projects have now been nominated for funding. Projects have started at the end of 2014 or beginning of 2015.
Research spotlights from this call:
- NACPLI: Non-conventional approaches for peptidoglycan cross-linking inhibition (pdf 0,2 MB, opens in a new window)
- noTBSec: New intervention strategy for tuberculosis by blocking multiple essential targets (pdf 0,2 MB, opens in a new window)
- SENBIOTAR: Sensitising Pseudomonas aeruginosa biofilms to antibiotic and reducing virulence through novel target inhibition (pdf 0,2 MB, opens in a new window)
Video
We are pleased to share a video, made by the team in the project SENBIOTAR.
Funded projects in this call:
-
-
-
- Non-conventional approaches for peptidoglycan cross-linking inhibition
Coordinator: Michel Arthur, INSERM, France
Partners: Waldemar Vollmer, Newcastle Univ, UK
Tanneke den Blaauwen, Univ of Amsterdam, Netherlands
Jean-Pierre Simorre, CNRS, France
John Mc Kinney, Swiss Federal Institute of Technology Lausanne Switzerland
Natalie Strynadka, Univ of British Columbia, Canada
Fact sheet on the Project: Non-conventional approaches for peptidoglycan cross-linking inhibition
- Sensiting Preudomonas aeruginosa biofilms to antibiotic and reducing virulencec through novel target inhibition
Coordinator: Miguel Camara, Univ of Nottingham, UK
Partners: Peter Nielsen, Univ of Copenaghen Denmark
Roger Levesque, Univ of Laval, Canada Christel Bergström, Uppsala Univ, Sweden
Fact sheet on the Project: Sensiting Preudomonas aeruginosa biofilms to antibiotic and reducing virulence through novel target inhibition
- Repotentiating Beta Lactam antibiotics
Coordinator: Mariel Pikkemaat, RIKILT-Wageningen UR, as part of stichting DLO, Netherlands
Partners: Natalie Strynadka, Univ of British Columbia, Canada
Fredrik Almqvist, Umeå Univ, Sweden
Fact sheet on the Project: Repotentiating Beta Lactam antibiotics
- Structure-guided design of pan inhibitors of metallo-p-lactamases
Coordinator: Thierry NAAS, Univ Paris Sud, France
Partners: Youri Glupczynski, CHU Dinant Godinne UCL, Belgium
Bogdan Iorga, Centre National de la Recherche Scientifique (CNRS) France
Mariusz Jaskolski, Institute of Bioorganic Chemistry, Polish Academy of Science, Poland
Fact sheet on the Project: Structure-guided design of pan inhibitors of metallo-p-lactamases
- New intervention strategy for tubercolosis: blocking multiple essential targets
Coordinator: Willbert Bitter, VU Univ Medical center, Netherlands
Partners: Roland Brosch, Institut Pasteur, France
Magnus Steigedal, Norwegian Univ of Science and Technology, Norway
Charles Thompson, Univ of British Columbia, Canada
Stewart Cole, École polytechnique fédérale de Lausanne, Switzerland
Fact sheet on the Project: New intervention strategy for tuberculosis: blocking multiple essential targets
- Non-conventional approaches for peptidoglycan cross-linking inhibition
-
-
-
-
- Capturing the natural antibiotic´ome: Developing Nature´s EVOLved AntiBIOTIC
Coordinator: Nathan Magarvey, McMaster Univ, Canada
Partners: Julian Davies, Univ of British Columbia, Canada
Eliora Ron, Tel Aviv Univ, Israel
Raymond Andersen, Univ of British Columbia, Canada
Jean-Luc Pernodet, Paris-Sud Univ, France
Gregory Challis, Univ of Warwick, UK
Fact sheet on the Project: Capturing the natural antibiotic’ome: Developing Nature’s EVOIved AntiBIOTIC Collective
- Investigating the Mechanism of Eradication of Multi Drug Resistant Bacteria by Inorganic (mixed metal oxides), Organic (antibiotic) and PROJECT is RELATED to Protein-based Nanoparticles
Coordinator: Aharon Gedanken, Bar-llan Univ, Israel
Partners: Horacio Bach, Univ of British Columbia, Canada
Tzanko Tzanov, Univsitat Politecnica de Calunya, Spain
EhudBarin, Bar-llan Univ, Israel
Urs Hafelli, Univ of British Columbia, Canada
Fact sheet on the Project: Investigating the Mechanism of Eradication of Multi Drug Resistant Bacteria by Inorganic (mixed metal oxides), Organic (antibiotic), and PROJECT is RELATED TO Protein-based Nanoparticles
- Capturing the natural antibiotic´ome: Developing Nature´s EVOLved AntiBIOTIC
-
Click on the link below to view more information about the call.
Joint Call “Transnational call InnovaResistance: Innovative approaches to address antibacterial resistance” – call information